Phreesia (NYSE:PHR) PT Raised to $34.00

Phreesia (NYSE:PHR) had its price objective hoisted by Robert W. Baird from $31.00 to $34.00 in a report issued on Friday morning, Benzinga reports. Robert W. Baird currently has an outperform rating on the stock.

Other equities research analysts have also recently issued reports about the company. KeyCorp decreased their price target on Phreesia from $27.00 to $25.00 and set an overweight rating on the stock in a report on Thursday, July 11th. Needham & Company LLC restated a buy rating and set a $29.00 price objective on shares of Phreesia in a research report on Thursday, September 5th. Royal Bank of Canada restated a sector perform rating and set a $23.00 price objective on shares of Phreesia in a research report on Thursday, September 5th. Stephens restated an overweight rating and set a $28.00 price objective on shares of Phreesia in a research report on Friday, May 31st. Finally, Canaccord Genuity Group restated a buy rating and set a $34.00 price objective on shares of Phreesia in a research report on Thursday, September 5th. One investment analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat.com, Phreesia currently has an average rating of Moderate Buy and an average target price of $30.23.

Phreesia Price Performance

NYSE:PHR opened at $23.91 on Friday. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.03. The business’s 50-day simple moving average is $23.44 and its two-hundred day simple moving average is $22.75. The stock has a market cap of $1.37 billion, a PE ratio of -11.02 and a beta of 0.93. Phreesia has a 52 week low of $12.05 and a 52 week high of $29.16.

Insider Buying and Selling

In related news, General Counsel Allison C. Hoffman sold 14,110 shares of Phreesia stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $26.03, for a total value of $367,283.30. Following the completion of the transaction, the general counsel now owns 121,003 shares in the company, valued at $3,149,708.09. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In other Phreesia news, General Counsel Allison C. Hoffman sold 14,110 shares of the business’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $26.03, for a total transaction of $367,283.30. Following the completion of the transaction, the general counsel now owns 121,003 shares in the company, valued at $3,149,708.09. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Chaim Indig sold 2,644 shares of the business’s stock in a transaction that occurred on Tuesday, July 16th. The shares were sold at an average price of $23.74, for a total value of $62,768.56. Following the transaction, the chief executive officer now owns 1,219,361 shares of the company’s stock, valued at approximately $28,947,630.14. The disclosure for this sale can be found here. Over the last quarter, insiders sold 29,337 shares of company stock worth $736,750. Corporate insiders own 5.80% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of the business. Select Equity Group L.P. boosted its position in shares of Phreesia by 14.7% during the second quarter. Select Equity Group L.P. now owns 15,858 shares of the company’s stock valued at $336,000 after buying an additional 2,028 shares during the period. Deerfield Management Company L.P. Series C purchased a new position in shares of Phreesia during the second quarter valued at approximately $4,078,000. Squarepoint Ops LLC boosted its position in shares of Phreesia by 56.3% during the second quarter. Squarepoint Ops LLC now owns 250,396 shares of the company’s stock valued at $5,308,000 after buying an additional 90,215 shares during the period. Point72 DIFC Ltd purchased a new position in shares of Phreesia during the second quarter valued at approximately $209,000. Finally, Lombard Odier Asset Management USA Corp purchased a new position in shares of Phreesia during the second quarter valued at approximately $202,000. Hedge funds and other institutional investors own 92.10% of the company’s stock.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.